Formulation development and optimization of ibuprofen tablets by direct compression method

Pakistan Journal of Pharmaceutical Sciences

Volumn 21, Issue 2, 2008, Pages 113-120

  Bushra, Rabia ^a   Shoaib, Muhammad Harris ^a   Aslam, Nousheen ^a   Hashmat, Durriya ^a   Masud Ur Rehman, ^b  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b Ministry of Health   (Pakistan)

Author keywords

Direct compression; Ibuprofen; Independent variables; Optimization; Response variables

Indexed keywords

CROSPOVIDONE; DILUENT; DISINTEGRATING AGENT; IBUPROFEN; LUBRICATING AGENT; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; CELLULOSE; NONSTEROID ANTIINFLAMMATORY AGENT; POVIDONE; STEARIC ACID; STEARIC ACID DERIVATIVE;

ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SOLUBILITY; TABLET COMPRESSION; TABLET FRIABILITY; TABLET HARDNESS; TECHNIQUE; THICKNESS; WEIGHT; CHEMISTRY; DRUG DOSAGE FORM; SOLUBILITY; TABLET;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLULOSE; DOSAGE FORMS; IBUPROFEN; POVIDONE; SOLUBILITY; STEARIC ACIDS; TABLETS;

EID: 44449171518     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Abraham P and KI KD (2005). Nitro-arginine methyl ester, a non-selective inhibitor of nitric oxide synthase reduces Ibuprofen-induced gastric mucosal injury in the rat. Dig. Dis., 50(9): 1632-1640. (Pubitemid 41203655)
2. th ed., Lippincott Williams And Wilkins, A Wolters Kluwer company, Philadelphia, Baltimore, pp.227-259.
3. nd edn., Vol.03, Marcel Dekker, Inc., New York, Basel, p.2723.
4. Beyer T, Day GM and Price SL (2001). The prediction, morphology and mechanical properties of the polymorphs of Paracetamol. J. Am. Chem. Soc., 123: 5086-5094. (Pubitemid 32905664)
5. th ed. Lippincott Williams and Wilkins A Wolters Kluwer Company, Philadelphia, Baltimore, New York, p.63.
6. Bos CE, Bolhius GK and Lerk CF (1991). Optimization of tablet formulation based on starch/lactose granulation for use in tropical countries. Drug Dev. Ind. Pharm., 17(17): 2373-2389.
7. British Pharmacopoeia (2004).The Stationary Office, London, pp.2499, A358.
8. Caldwell HC (1974). Dissolution of Lithium and Magnesium from Lithium carbonate capsules containing Magnesium stearate. J. Pharm. Sci., 63: 770-773.
9. Ceshel GC, Maffei P and Badiello R (1999). Optimization of hydrochlorothiazide tablets. Drug Dev. Ind. Pharm., 25(11): 1187-11176
10. Garcia- Marquez MA, Munoz A and Jimenez-Castellanos MR (1992). The effect of two lubricants (Magnesium stearate and Pruv) in the formation of tablets of four anti-ulcer agents/ by means of direct compression. Pharm Acta Helv., 67(2): 50-56.
11. Gazikolovic E, Obrenovic D and Nidzovic Z (1999). Manufacture of Lithium carbonate tablets using direct compression. Vojnosanit. Preg., 56(4): 389-392.
12. Gohel MC (2005). A review of Co-processed Directly compressible excipients. J. Pharm. Sci., 8(1): 76-93.
13. Goutte F, Guemguem F, Dragan C, Vergnault G and Wehrle P (2002). Power of experimental design studies for the validation of pharmaceutical processes: case study of a multilayer tablet manufacturing process. Drug Dev. Ind. Pharm., 28(7): 841-848. (Pubitemid 34977802)
14. Halbert G W (1993). Pharmaceutical Development. In: Griffin JP, Grady JO and Wells FO editors. The Text Book of Pharmaceutical Medicine. Greystone Books Ltd., Caulside Drive, Antrim, N. Ireland, pp.39- 40.
15. th ed., Pharmaceutical Press, London, Chicago, pp.183-184.
16. Hernier AP and Teleman O (1997). Interface between Monoclinic Crystalline Cellulose and Water: Break down of the oddf even duplicity. Langmuir, 13: 511-518.
17. Hussain MSH, York P and Timmins P (1992). Effect of commercial and high purity Magnesium stearate on in vitro dissolution of Paracetamol DC tablets. Int. J. Pharm., 78: 203-207.
18. Ibrahim and Olurinola (1991). Comperative microbial contamination levels in wet granulation and direct compression methods of tablet production. Pharm. Acta. Helv., 66: 293-301.
19. Jivraj M, Martini LG and Thomson CM (2000). An overview of different excipients useful for the direct compression of tablets. Pharm. Sci. Technol., 3(2): 58-63. (Pubitemid 30101632)
20. Kesavan JG and Peck GE (1996). Pharmaceutical granulation and tablet formulation using neural networks. Pharm. Dev. Technol., 1(4): 391-404.
21. Khairuzzaman A, Ahmed SU, Savva M and Patel NK (2006). Zero-order release of Aspirin, Theophylline and Atenolol in water from novel Methylcellulose glutarate matrix tablets. Int. J. Pharm., 318(1-2): 15-21. (Pubitemid 43963298)
22. th Edn. Lippincott William and Wilkins. A Wolters Kluwer Company, Philadelphia, ch. 94, p.23.
23. Levy G and Gumtow RH (1963). Effect of certain formulation factors on dissolution rate of the active ingredient III: tablet Lubricants. J Pharm Sci., 52: 1139-1144.
24. Mackin L, Sartnurak S, Thomas I, and Moore S (2002). The impact of low levels of amorphous material (<5%) on the blending characteristics of a direct compression formulation. Int J Pharm., 231(2): 213-226. (Pubitemid 34033680)
25. Martinello T, Kaneko TM, Velasco MVR, Taqueda MVS and Consiglieri VO (2006). Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design. Int. J. Pharm., 322 (1-2): 87-95. (Pubitemid 44339597)
26. Martino PD, Joiris E and Martelli S (2004). Particle interaction of lubricated or un lubricated binary mixtures according to their particle size and densification mechanism II. Farmaco., 59(9): 747-758. (Pubitemid 39150038)
27. Moore N (2003). Forty years of Ibuprofen use. Int. J. Clin. Pract. 135(Suppl.): 28-31.
28. Moore PA and Hersh EV (2001). Celecoxib and Rofecoxib. The role of COX-2 inhibitors in dental practice. J Am Dent Assoc. 132(4): 451-456.
29. Omray A and Omray P (1986). Evaluation of microcrystalline cellulose as a glidant. Indian J. Pharm. Sci., 48: 20-22.
30. th edn., The Pharmaceutical Press, London, pp. 9-11.
31. Potthast H, Dressman JB, Junginger HE, Midha KK, Oeser H, Shah VP, Vogelpoel H and Barends DM (2005). Biowaiver monographs for immediate release solid oral dosage forms: Ibuprofen. Journal of pharmaceutical sciences, 94(10): 2122. (Pubitemid 41670501)
32. Prescott JK and Hossfield RJ (1994). Maintaining product uniformity and uninterrupted flow to direct-compression tableting press. Pharmaceutical technology, 18 (6): 99-114.
33. Rasenack N and Muller BW (2002). Ibuprofen crystals with optimized properties. Int. J. Pham., 245(Suppl 1-2): 9-24.
34. th ed., Bailliere Tindall, London, pp. 289-290.
35. Rhodes CT, Dawoodbhai S, Suryanarayan ER and Woodruff CW (1991). Optimization of tablet formulations containing talc. Drug Dev.Ind.Pharm., 17(10):1343-1371.
36. Shangraw RF (1989). In: Liberman HA, Lachman L and Schwartz JB editors. Pharmaceutical Dosage Forms: Tablets, Vol.01 , Mercel Dekker, Inc., New York, pp.109-164.
37. Tan SC, Patel BK, Jackson SH, Swift CG and Hutt AJ (1999). Ibuprofen stereochemistry: double-the-trouble? Enantiomer., 4(3-4): 195-203.
38. Terashita K and Imamura K (2002). Preparation of antipyretic analgesic by direct compression and its evaluation. Chem. Pharm. Bull. (Tokyo). 50(12): 1542-1549.
39. Turkoglu M, Sahin I and San T (2005). Evaluation of hexagonal boron nitride as a new tablet lubricant. Pharm. Dev. Technol., 10(3): 381-388. (Pubitemid 41291475)
40. United State Pharmacopoeia 2005. (USP 27 NF 22) convention INC., pp.2308-2309.
41. Wood DM, Monaghan J, Streete P, Jones AL and Dargan PI (2006). Fatality after deliberate ingestion of sustained- release Ibuprofen; a case report. Critical Care. 10:R44. (Pubitemid 47086798)
42. Yasmeen R, Shoaib MH and Khalid H (2005). Comparative Study of Different Formulations of Atenolol. Pak. J. Pharm Sci., 18(1): 49.
43. Zhang Y, Law Y and Chakrabarti S (2003). Physical Properties and Compact Analysis of Commonly Used Direct Compression Binders. AAPS Pharm. Sci. Tech., 4(4): 1-11. (Pubitemid 41086186)